No abstract available.
Low Back Pain*

No abstract available.
Rabbits* ; Regeneration*

No abstract available in English.
Arthroplasty, Replacement, Hip ; Peripheral Nervous System Diseases

No abstract available.
Humans ; Myotonia* ; Myotonic Dystrophy*

No abstract available.
Evoked Potentials, Motor* ; Paresis*

No abstract available.
Rett Syndrome*

No abstract available.
Paralysis*

OBJECTIVE: To investigate bone mineral density (BMD) and biochemical markers of bone turnover in cerebral palsy patients according to the severity and type. METHOD: BMD and biochemical markers of bone turnover were examined in 30 normal children and 57 children with cerebral palsy. They were 10 to 15 years old and divided into 5 groups: Group I, 30 normal children; Group II, 11 with moderate spastic cerebral palsy; Group III, 10 with moderate non-spastic cerebral palsy; Group IV, 24 with bed-ridden spastic cerebral palsy; Group V, 13 with bed-ridden non-spastic cerebral palsy. The bed-ridden cerebral palsy subjects were further divided into two groups: one with treatment of anticonvulsants more than 5 years; the other with no experience of anticonvulsants treatment. BMD and its T-score on the dominant forearm were measured in all subject, and the level of serum osteocalcin and urine deoxypyridinoline were measured in cerebral palsy patients in early morning. RESULTS: The bed-ridden cerebral palsy children were shorter, weighed less, and also showed significantly lower value of BMD and T-score on the distal radio-ulnar and the distal end of radial bones compared to those of the normal and the moderate cerebral palsy. These parameters were not significantly different between spastic and non-spastic types of same severity of cerebral palsy. There's no difference in the level of serum osteocalcin and urine deoxypyridinoline between each group of cerebral palsy. In cerebral palsy groups, the level of serum osteocalcin remained in the normal range of the same age group of the normal, however, the urine deoxypyridinoline levels were significantly higher than those of the same age groups of the normal. No difference in either BMD or biochemical markers of bone turnover was observed in bed-ridden cerebral palsy groups regardless of anticonvulsants treatment. CONCLUSION: A couple of factors accounting for lower BMD in bed-ridden cerebral palsy are as follows: 1) the increase in activity of bone resorption rather than formation, 2) the diminish of muscle use and the decrease of mechanical stresses on the bone. In addition, these results also suggest no effect of anticonvulsants on lower BMD.
Adolescent ; Anticonvulsants ; Biomarkers* ; Bone Density* ; Bone Resorption ; Cerebral Palsy* ; Child ; Forearm ; Humans ; Muscle Spasticity ; Osteocalcin ; Reference Values ; Stress, Mechanical

OBJECTIVE: The purposes of this study were to observe the radiographic changes of lumbar facet joints by magnetic resonance imaging (MRI) in conservatively and operatively treated groups of patients with herniated intervertebral disc, and to compare the biomechanical effects to lumbar facet joints according to the treatment methods. METHOD: The patients composed of 20 conservatively treated control group and 40 operatively treated group who had disc herniation at lower lumbar spine. Follow-up MRIs were performed in order to assess the radiographic changes of intervertebral disc and lumbar facet joints, such as disc degeneration, lumbar facet joint angle and tropism in either treatment groups individually. RESULTS: There are significant increase in lumbar facet joint angle in operatvely treated group at the level of both L4/5, right L5/S1 compared to that of conservately treated group, but the disc degeneration and facet joint tropism were not changed after treatment in both groups. There's no relationship between treatment period and each parameters. CONCLUSION: The radiographic biomechanical lumbar facet joint changes on MRI seems to be related to degenerative change of lumbar facet joint in operatively treated group with a lumbar disc herniation. Therefore, careful selection of optimal operation time and criteria would be important.
Follow-Up Studies* ; Humans ; Intervertebral Disc Degeneration ; Intervertebral Disc* ; Magnetic Resonance Imaging* ; Spine ; Tropism ; Zygapophyseal Joint*

OBJECTIVE: To evaluate the efficacy of intraarticular injection of hyaluronic acid and steroid in adhesive capsulitis of shoulder. METHOD: Thirty-nine patients with adhesive capsulitis of shoulder were assigned at random to receive intraarticular injection into the glenohumeral joint. The treatment groups were divided into three: group A, triamcinolone 1 ml and 1% lidocaine 3 ml and normal saline 25 ml; group B, hyaluronic acid 2 ml and 1% lidocaine 3 ml and normal saline 25 ml; group C, hyaluronic acid 2 ml and 1% lidocaine 3 ml. The same physical therapy program was carried out for all patients. Pain was assessed by visual analogue scale (VAS) and range of motion (flexion, abduction, internal rotation and external rotation) was measured before injection, and at 30 minutes, 1 week and 2 weeks after injection. RESULTS: The shoulder range of motion (ROM) and VAS of three groups were all improved at 30 minutes, 1 week and 2 weeks after injection compared with those of preinjection, but there was no significant difference in ROM and VAS among three groups. CONCLUSION: We concluded that intraarticular injection of hyaluronic acid would be a good treatment method in adhesive capsulitis of shoulder, specially in patients with risk of steroid use.
Adhesives* ; Bursitis* ; Humans ; Hyaluronic Acid* ; Injections, Intra-Articular* ; Lidocaine ; Range of Motion, Articular ; Shoulder Joint ; Shoulder* ; Triamcinolone